Here, we identified HDACi as potent inhibitors of MYB gene expression also in lymphoid leukemia cells, suggesting a conserved mechanism of MYB gene regulation in neoplasms of both the myeloid and lymphoid lineages. The gene discussed is MYB; the disease is lymphoid leukemia.